⌘K

Login Start Free

Home/Filings/4/A/0000897069-25-000296

4/A//SEC Filing

Yorke Justin W 4/A

Accession 0000897069-25-000296

CIK 0001533743other

View on SEC.gov Company Profile

Filed

Feb 17, 7:00 PM ET

Accepted

Feb 18, 5:59 PM ET

Size

9.4 KB

Accession

0000897069-25-000296

Insider Transaction Report

Form 4/AAmended

Period: 2025-01-27

Processa Pharmaceuticals, Inc.PCSA

Director

Transactions

Award
Warrants
2025-01-29+12,400→ 12,400 total(indirect: By Trust)
Exercise: $0.65From: 2025-01-29Exp: 2030-01-29→ Common Stock (12,400 underlying)
Award
Warrants
2025-01-29+6,200→ 6,200 total(indirect: By Trust)
Exercise: $0.65From: 2025-01-29Exp: 2030-01-29→ Common Stock (6,200 underlying)

Holdings

Common Stock
(indirect: By LLC)
31,232
Common Stock
3,737
Common Stock
(indirect: By Trust)
12,400

Documents

1 file

4
form4.xml

Issuer

Processa Pharmaceuticals, Inc.

CIK 0001533743

Entity typeother

Related Parties

1

filerCIK 0001361896

Filing Metadata

Form type: 4/A
Filed: Feb 17, 7:00 PM ET
Accepted: Feb 18, 5:59 PM ET
Size: 9.4 KB

View on SEC.gov